海普瑞(9989.HK)今日盘中一度大涨超28%至5.11港元;海普瑞(002399.SZ)临近午盘涨停,并封住涨停直至收盘。海普瑞昨日晚间公布,2025年2月17日,深圳市海普瑞药业集团股份有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》(受理号:CXHL2401312,通知书编号:2025LP00375),批准注射用H1710开展临床试验。H1710是海普瑞自主研发的候选药物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.